【Area 1】
K22-1039
Ferritin nanocaged doxorubicin for targeted hepatocellular carcinoma therapy
K22-1040
Reconstruction of human liver in Fah–/–Rag2–/–IL2rg–/– rats with hiPSC derived liver organoids
K22-1059
Mesenchymal Stromal Cell Therapy to Prevent Neurodevelopmental Disorders related to Low-Birth-Weight
K22-1073
Hematopoietic stem cell rejuvenation therapies
K23-1050
Structural basis of ribosome associated quality control
K24-1114
Uncovering human neural differentiation by advanced multi-omics for the regeneration of brain function
K24-1115
The study of primed-umbilical cord-derived mesenchymal stromal cells to improve immunosuppressive properties in the treatemnet of GVHD
K24-1116
Deciphering and targeting EZH2 non-canonical activities to overcome therapy resistance in acute myeloid leukemia.
K24-1117
Functional interplay between endogenous MLL1/KMT2A and MLL-fusion oncoproteins
K24-1118
Structures of the Gcn2 kinase on the ribosome
K24-1119
Deciphering Molecular Dynamics of the APC/C ubiquitin system: Advanced IDR Visualisation and APC/C-Ribosome Interactions
【Area 2】
K22-2043
Understanding of epigenetic heterogeneity in intractable cancers
K22-2056
Functional polarization of tumour-associated macrophages by tumor microenvironment
K22-2057
Regulation and Function of DNA methylation
K22-2103
The development of acral melanoma model and a novel early diagnostic method based on stem cell dynamics
K23-2042
Identification of the cellular behavior in xenogenic environment in interspecies chimaera
K23-2090
Genome stability and DNA methylation
K23-2093
Functional interrogation of house-keeping enhancers’ role in cancer
K24-2120
Exploration of the functional role of FOXP1 in the development of secondary myelofibrosis
K24-2121
Cell Technology for Testing Indonesian Natural Products as Anticancer and Antiaging Agents
K24-2122
Regulation of DNA methylation on the nucleosome
K24-2125
Deep learning-based multi-modal approaches for pan-cancer prognosis and cancer-specific biomarker discovery
【Area 3】
K22-3045
Development of mucosal vaccines designed for infant based on the understanding of the infantile nasopharyngeal and gut mucosal immune system
K22-3046
Control of T cell and NK cell exhaustion to overcome viral infection and cancer development
K22-3062
Harnessing the group A streptococcus pilus to develop novel universal influenza vaccines
K22-3063
Human Systems Immunology of vaccine and immunotherapy
K22-3069
To study the molecular mechanism of COVID-19 protein ORF3a to stimulate the production of cytokine in macrophages
K22-3076
Elucidation of mechanisms involved in tissue specific immunity during infection and vaccination
K22-3082
Analysis of the mechanisms of co-infection with Mycobacterium and HIV in human macrophage linage cells
K23-3044
Development of a mucosal vaccine against Strep A infections
K23-3086
The role of lysosomal RNase T2 in RNA-sensing Toll-like receptor responses
K23-3095
Prediction and monitoring of SARS-CoV-2 emerging lineages
K24-3123
Immunopathology of, and Response to, Protozoan Parasites
K24-3124
Discovery of antibodies with potential therapeutic applications aided by machine learning and artificial intelligence.